M & A Tracker - April 2015
In terms of sectors, the Banking Financial Service and Insurance (BFSI) saw the maximum deal value with deals worth around $1.4 billion, followed by Pharmaceuticals, Biotechnology & Life Sciences with $988 million.
India
Corporate/Commercial Law
M&A in India - Q1 2015
During Q1 2015, around 225 M&A deals were completed
aggregating to approx. $5.5 billion; this was an increase of 10% in
terms of deal value and 8% in deal volume from Q1 2014, which saw
approx. $5 billion worth of acquisitions completed spread across
207 deals.
In terms of sectors, the Banking Financial Service and Insurance
(BFSI) saw the maximum deal value with deals worth around $1.4
billion, followed by Pharmaceuticals, Biotechnology & Life
Sciences with $988 million.
India-UK specific deal announcements
No. |
Target Company |
Acquiring Company |
Deal Value |
Deal Highlights |
1 |
Prime Focus Ltd., UK Broadcast Post Production Business |
Blue 2.0 |
Undisclosed |
- India based entertainment service company Prime Focus Ltd. is
divesting its UK broadcast post-production business to a new firm
Blue 2.0.
- Blue 2.0 will take over Prime Focus' UK broadcast facility
at 58 Old Compton Street and the provision of its long-form, drama,
short-form, entertainment and DI services.
|
2 |
Sublime Food Ltd. |
Future Consumer Enterprise Ltd. |
Undisclosed |
- Future Consumer Enterprise Ltd., part of the Future Group,
announced that it has bought 51% stake in food and confectionery
manufacturer Sublime Food Ltd.
- Future Group has made an investment by way of subscription to
the equity shares of Sublime. After the share purchase, Sublime has
become a subsidiary of Future Consumer Enterprise Ltd.
|
Key India-related Deals
No. |
Target Company |
Acquiring Company |
Deal Value |
Deal Highlights |
1 |
Famy Care Ltd., Women's Health Business |
Mylan Inc. |
$ 800 million |
- US based pharmaceuticals major Mylan Inc. has signed a deal to
acquire the female health care business of Famy Care Ltd. a
specialty women's health care company.
- The deal is valued at $800 million of which $750 million will
be paid in cash with additional contingent payments of up to $50
million.
- Famy Care Ltd. will spin off its women's healthcare
business under a court order-approved scheme of de-merge. Post the
de-merger, Mylan Inc. will acquire the shares of the new
Company.
|
2 |
Videocon D2H Ltd. |
Silver Eagle Acquisition Corp. |
$ 325 million |
- US based Silver Eagle Acquisition Corp. will acquire up to
38.6% stake in direct to home distribution firm Videocon D2H
Ltd.
- The deal is valued at $ 325 million.
- The shares issued by Videocon D2H Ltd. will be represented by
American Depositary Shares.
|
3 |
Panaya Inc. |
Infosys Ltd. |
$ 200 million |
- Infosys Ltd. announced to fully acquire Panaya Inc., a leading
provider of automation technology for large scale enterprise
software management companies.
- Infosys Ltd. will acquire Panaya Inc. in an all cash
transaction.
- The acquisition of Panaya Inc. is a key step in renewing and
differentiating Infosys Ltd's service lines.
|
4 |
Green Infra Ltd. |
SembCorp Utilities Pte. Ltd. |
$ 169 million |
- Singapore based SembCorp Utilities Pte. Ltd. acquiring 60%
stake in Green Infra Ltd. for approx. $ 169 million.
- Green Infra Ltd. was incubated by private equity firm IDFC
Alternatives. This transaction will result in IDFC Private Equity
Fund II exiting completely and IDFC Private Equity Fund III
continuing to hold 40% stake in the Company.
|
5 |
GlaxoSmithKline Plc - Opiates Business |
Sun Pharmaceutical Industries Ltd. |
Undisclosed |
- Sun Pharmaceutical Industries Ltd. has agreed to buy
GlaxoSmithKline's opiates business in Australia.
- Sun Pharmaceutical expects to close the deal by August
2015.
|
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.